Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
CytoDyn Inc. (CYDY) had Return on Equity of 20.33% for the most recently reported fiscal quarter, ending 2026-08-31.
| Income Statement Financials | |
-- |
|
$-19.94M |
|
-- |
|
-- |
|
$6.58M |
|
$-6.58M |
|
$-13.36M |
|
$-19.94M |
|
$-19.94M |
|
$-19.94M |
|
$-19.94M |
|
$-19.94M |
|
$-19.94M |
|
$-6.58M |
|
$-6.56M |
|
1.38B |
|
1.38B |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$18.98M |
|
-- |
|
$0.07M |
|
$19.05M |
|
$49.70M |
|
$23.81M |
|
$67.43M |
|
$117.13M |
|
$-98.07M |
|
$-98.07M |
|
$-98.07M |
|
1.45B |
|
| Cash Flow Statement Financials | |
$-7.73M |
|
-- |
|
$12.23M |
|
$11.85M |
|
$16.36M |
|
$4.51M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.38 |
|
-- |
|
-- |
|
-0.32 |
|
-0.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
20.33% |
20.33% |
|
-104.63% |
|
26.84% |
|
$-0.07 |
|
$-0.01 |
|
$-0.01 |
|